Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Zelda Therapeutics Ltd (ZLDAF)

Zelda Therapeutics Ltd (ZLDAF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ZLDAF with:
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.3778 +28.51%
on 08/01/24
0.4855 unch
on 08/23/24
-0.0669 (-12.11%)
since 07/15/24
3-Month
0.1912 +153.92%
on 06/25/24
0.5524 -12.11%
on 07/15/24
-0.0095 (-1.92%)
since 05/08/24
52-Week
0.1912 +153.92%
on 06/25/24
0.6880 -29.43%
on 11/27/23
-0.4288 (-46.90%)
since 08/15/23

Most Recent Stories

More News
Zelira Therapeutics Launches ZYRAYDIâ„¢ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets

/PRNewswire/ -- Zelira Therapeutics Ltd (ASX:ZLD, OTCQB:ZLDAF), a global leader in the research, development and commercialization of clinically validated...

ZLDAF : 0.4855 (+0.94%)
Zelira's Zenivolâ„¢, the World's First Clinically Validated Cannabinoid Medication for Insomnia, Achieves Regulatory Approval in Germany

/PRNewswire/ -- Zelira Therapeutics Ltd (ASX: ZLD, OTC-QB: ZLDAF), a global leader in the research, development and commercialization of clinically validated...

ZLDAF : 0.4855 (+0.94%)
Proactive news headlines including Volt Resources, Orthocell, Zelira Therapeutics and Tempus Resources

Sydney, June 21, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

OCC : 2.68 (+1.13%)
ZLDAF : 0.4855 (+0.94%)
TMRR : 0.0600 (-11.89%)
TMRFF : 0.0200 (unch)
AZI : 1.0600 (-3.64%)
RPM : 125.00 (+1.89%)
Proactive news headlines including Shree Minerals, Emperor Energy, SUDA Pharmaceuticals and Zelira Therapeutics

Sydney, June 18, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

EMP : 23.36 (+0.52%)
ZLDAF : 0.4855 (+0.94%)
ARU : 25.20 (-0.32%)
ARAFF : 0.1200 (unch)
DNK : 2.37 (+0.72%)
DNK.LN : 20.000 (unch)
DNKLY : 0.2429 (+2.49%)
AXE : 97.85 (-0.02%)
ARRXF : 0.1318 (-32.96%)
PAR : 57.16 (+1.29%)
PBIGF : 0.1718 (+8.73%)
KIN : 9.25 (+0.11%)
Proactive news headlines including Element 25, Bellevue Gold, Zelira Therapeutics and St George Mining

Sydney, April 15, 2021 (GLOBE NEWSWIRE) -- Proactive, provider of real-time news and video interviews on growth companies listed in Australia, has covered the following companies:

BELGF : 0.8800 (+1.34%)
ZLDAF : 0.4855 (+0.94%)
FYIRF : 0.0359 (-64.10%)
HLX : 10.39 (+5.59%)
MXC : 11.96 (+4.52%)
MXC.LN : 22.000 (unch)
MGCLF : 0.2675 (+2.88%)

Key Turning Points

3rd Resistance Point 0.4855
2nd Resistance Point 0.4855
1st Resistance Point 0.4855
Last Price 0.4855
1st Support Level 0.4855
2nd Support Level 0.4855
3rd Support Level 0.4855

See More

52-Week High 0.6880
Fibonacci 61.8% 0.4982
Last Price 0.4855
Fibonacci 50% 0.4396
Fibonacci 38.2% 0.3810
52-Week Low 0.1912

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar